Don’t miss the opportunity to meet the @Vivet Therapeutics leadership team who will be participating in a jam-packed schedule at the event.

👂Listen in as our Co-Founder and CSO, Dr @Gloria Gonzalez Aseguinolaza deliberates on the latest developments in gene therapy for liver disease in an oral presentation and panel discussion.

Also check out our three poster📜presentations presented by Research Scientist, @Laia Trigueros Motos and PhD Apprentice, Andrea Llanos Ardaiz. See details on where you can find the team in action in the full agenda here👉https://bit.ly/487E7Xh

As a proud sponsor of #ESGCT2024, Vivet’s leadership team comprised of CEO @Jean-Philippe Combal, COO @Anne Douar, Senior Project Leaders @Celine Bouquet and @Veronica Ferrer, Principal Scientist @Nicholas Weber will be in attendance to provide further information on #Vivet’s diversified recombinant AAV-based #genetherapy pipeline.